{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:46:34Z","timestamp":1792608394314,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ajem.2019.04.035","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:56:21Z","timestamp":1555671381000},"page":"1346-1352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis"],"prefix":"10.1016","volume":"37","author":[{"given":"Yabo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ajem.2019.04.035_bb0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ajem.2019.04.035_bb0015","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ajem.2019.04.035_bb0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/hrt.2003.031369","article-title":"FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease","volume":"91","author":"Lagerkvist","year":"2005","journal-title":"Heart"},{"issue":"22","key":"10.1016\/j.ajem.2019.04.035_bb0025","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajem.2019.04.035_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9149(01)02204-4","article-title":"Association of C-reactive protein and serum amyloid a with recurrent coronary events in stable patients after healing of acute myocardial infarction","volume":"89","author":"Harb","year":"2002","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.ajem.2019.04.035_bb0035","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1001\/jama.294.22.2866","article-title":"Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease","volume":"294","author":"Morrow","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajem.2019.04.035_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2004.10.057","article-title":"Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast revascularisation during in stability in coronary artery disease (FRISC)-II substudy","volume":"45","author":"Lindahl","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ajem.2019.04.035_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2009.03.056","article-title":"Prognostic value of biomarkers during and after non-ST segment elevation acute coronary syndrome","volume":"54","author":"Eggers","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"9050","key":"10.1016\/j.ajem.2019.04.035_bb0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ajem.2019.04.035_bb0055","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ajem.2019.04.035_bb0060","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2019.04.035_bb0065","doi-asserted-by":"crossref","unstructured":"Wilson PW, Nam BH, Pencina M, D'Agostino RB Sr, Benjamin EJ, O'Donnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham heart study. Arch Intern Med 2005; 165 (21): 2473\u20138.","DOI":"10.1001\/archinte.165.21.2473"},{"issue":"1","key":"10.1016\/j.ajem.2019.04.035_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/CS20080419","article-title":"N-terminal pro B type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndromes","volume":"117","author":"Khan","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"7704","key":"10.1016\/j.ajem.2019.04.035_bb0075","first-page":"1195","article-title":"Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study","volume":"338","author":"Lorgis","year":"2009","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.ajem.2019.04.035_bb0080","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ajem.2019.04.035_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","article-title":"Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1)","volume":"237","author":"Bottner","year":"1999","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.ajem.2019.04.035_bb0090","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","article-title":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury","volume":"20","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"issue":"19","key":"10.1016\/j.ajem.2019.04.035_bb0100","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/eurheartj\/ehn339","article-title":"Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain","volume":"29","author":"Eggers","year":"2008","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajem.2019.04.035_bb0105","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1016\/S0735-1097(14)60020-6","article-title":"Growth differentiation Factor-15 level predicts recurrent cardiovascular events in patients with an acute coronary syndrome in MERLIN-TIMI 36","volume":"63","author":"May","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ajem.2019.04.035_bb0110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ahj.2015.02.019","article-title":"Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the platelet inhibition and patient outcomes trial","volume":"169","author":"Velders","year":"2015","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.ajem.2019.04.035_bb0115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study","volume":"37","author":"Hagstr\u00f6m","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ajem.2019.04.035_bb0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1373\/clinchem.2016.261271","article-title":"Biomarkers and coronary lesions predict outcomes after revascularization in non-ST-elevation acute coronary syndrome","volume":"63","author":"Lindholm","year":"2017","journal-title":"Clin Chem"},{"issue":"14","key":"10.1016\/j.ajem.2019.04.035_bb0125","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.107.697714","article-title":"Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome","volume":"116","author":"Wollert","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ajem.2019.04.035_bb0130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation Factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ajem.2019.04.035_bb0135","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehm465","article-title":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction","volume":"28","author":"Kempf","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajem.2019.04.035_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCGENETICS.109.877456","article-title":"Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome","volume":"3","author":"Eggers","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"Kempf","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"8","key":"10.1016\/j.ajem.2019.04.035_bb0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/hrt.2010.219543","article-title":"Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance","volume":"97","author":"Eitel","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ajem.2019.04.035_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/ATVBAHA.110.213512","article-title":"Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22","volume":"31","author":"Bonaca","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ajem.2019.04.035_bb0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijcard.2014.01.025","article-title":"Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an invasive versus conservative treatment in unstable coronary syndromes (ICTUS) substudy","volume":"172","author":"Damman","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajem.2019.04.035_bb0165","doi-asserted-by":"crossref","unstructured":"Wright, R.S., Anderson, J. L., Adams, C. D., Bridges, C.R., Jr, D. E. C., & Ettinger, S. M., et al. 2011 ACCF\/AHA focused update of the guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the America n College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123 (18): 2022\u201360.","DOI":"10.1161\/CIR.0b013e31820f2f3e"},{"key":"10.1016\/j.ajem.2019.04.035_bb0170","doi-asserted-by":"crossref","unstructured":"Borja I, Stefan J, Stefan A, Manuel J Antunes, Chiara Bucciarelli-Ducci, H\u00e9ctor Bueno, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39(2): 119\u201377.","DOI":"10.1093\/eurheartj\/ehx393"},{"issue":"7578","key":"10.1016\/j.ajem.2019.04.035_bb0175","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.ajem.2019.04.035_bb0180","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ajem.2019.04.035_bb0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/ehi700","article-title":"Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction","volume":"27","author":"Chang","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ajem.2019.04.035_bb0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCINTERVENTIONS.109.925180","article-title":"A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the assessment of Pexelizumab in acute myocardial infarction trial","volume":"3","author":"Stebbins","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.ajem.2019.04.035_bb0195","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1161\/01.CIR.0000131765.73959.87","article-title":"Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ajem.2019.04.035_bb0200","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2005.01.041","article-title":"Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score","volume":"45","author":"Halkin","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00019501-200505000-00008","article-title":"Risk prediction in patients with chest pain: early assessment by the combination of troponin I results and electrocardiographic findings","volume":"16","author":"Eggers","year":"2005","journal-title":"Coron Artery Dis"},{"issue":"2","key":"10.1016\/j.ajem.2019.04.035_bb0210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","article-title":"Circulating concentrations of growth differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay","volume":"53","author":"Kempf","year":"2007","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.RES.0000207919.83894.9d","article-title":"GDF15, a cardioprotective TGF-beta superfamily protein","volume":"98","author":"Ago","year":"2006","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ajem.2019.04.035_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ajem.2019.04.035_bb0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1014778713034","article-title":"Prognostic factors in breast cancer: current and new predictors of metastasis","volume":"6","author":"Hayes","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"10.1016\/j.ajem.2019.04.035_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0006-341X.2002.00001.x","article-title":"Model-checking techniques based on cumulative residuals","volume":"58","author":"Lin","year":"2002","journal-title":"Biometrics"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719302578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719302578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:42:50Z","timestamp":1760024570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675719302578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0735675719302578"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2019.04.035","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2019.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}